2 blue chip ASX 200 shares rated as buys

Are you wanting to boost your portfolio with some blue chip ASX 200 shares in May?

Then you might want to take a look at the blue chips listed below. Here's what you need to know about them:

Goodman Group (ASX: GMG)

The first blue chip ASX 200 share to look at is Goodman Group. It is a leading integrated commercial and industrial property company with a growing portfolio of warehouses, large scale logistics facilities, and business and office parks. 

Goodman Group has been growing at a consistently solid rate over the last few years. This has been driven by its successful strategy of investing in and developing high quality industrial properties in strategic locations.

Positively, this strong form has continued in FY 2021. In fact, just this morning the company released its third quarter update and revealed further solid growth.

As a result, management believes it is on course to achieve its FY 2021 guidance for operating profit of $1.2 billion and earnings per share growth of 12%.

One broker that is positive on the company is Citi. It currently has a buy rating and $21.00 price target on its shares.

Ramsay Health Care Limited (ASX: RHC)

Another ASX 200 blue chip share to look at is Ramsay Health Care. It is a leading private healthcare company with operations across the world.

Ramsay has been battling tough trading conditions over the last 12 months due to the pandemic. And while things are still not entirely back to normal, it has returned to growth in the ANZ market.

Looking ahead, the company looks well-placed to benefit from a backlog in surgeries in the near term and increased demand for healthcare services over the long term. 

In addition to this, the company has a strong balance sheet and the option of accelerating its growth through expansions and acquisitions.

Earlier this week Goldman Sachs retained its conviction buy rating and $75.00 price target on the company's shares. Its analysts are positive on its outlook and continue to expect Ramsay to outperform the market's expectations in FY 2021 and FY 2022.